Genomic profiles of lung cancer associated with idiopathic pulmonary fibrosis. Issue 1 (14th December 2017)

• Record Type: Journal Article
• Authors: Hwang, Ji An; Kim, Deokhoon; Chun, Sung‐Min; Bae, SooHyun; Song, Joon Seon; Kim, Mi Young; Koo, Hyun Jung; Song, Jin Woo; Kim, Woo Sung; Lee, Jae Cheol; Kim, Hyeong Ryul; Choi, Chang‐Min; Jang, Se Jin
• Is Part Of: Journal of pathology. Volume 244:Issue 1(2018)
• Page Start: 25
• Page End: 35
• Publication Date: 2017-12-14
• Subjects: idiopathic pulmonary fibrosis -- lung cancer -- genome -- next‐generation sequencing; Pathology -- Periodicals; 616.07
• DOI: 10.1002/path.4978
• Languages: English
• ISSNs: 0022-3417

Abstract

Abstract: Little is known about the pathogenesis or molecular profiles of idiopathic pulmonary fibrosis‐associated lung cancer (IPF‐LC). This study was performed to investigate the genomic profiles of IPF‐LC and to explore the possibility of defining potential therapeutic targets in IPF‐LC. We assessed genomic profiles of IPF‐LC by using targeted exome sequencing (OncoPanel version 2) in 35 matched tumour/normal pairs surgically resected between 2004 and 2014. Germline and somatic variant calling was performed with GATK HaplotypeCaller and MuTect with GATK SomaticIndelocator, respectively. Copy number analysis was conducted with CNVkit, with focal events determined by Genomic Identification of Significant Targets in Cancer 2.0, and pathway analysis (KEGG) with DAVID. Germline mutations in TERT (rs2736100, n = 33) and CDKN1A (rs2395655, n = 27) associated with idiopathic pulmonary fibrosis risk were detected in most samples. A total of 410 somatic mutations were identified, with an average of 11.7 per tumour, including 69 synonymous, 177 missense, 17 nonsense, 1 nonstop and 11 splice‐site mutations, and 135 small coding indels. Spectra of the somatic mutations revealed predominant C > T transitions despite an extensive smoking history in most patients, suggesting a potential association between APOBEC‐related mutagenesis and the development of IPF‐LC. TP53 (22/35, 62.9%) and BRAF (6/35, 17.1%) were found to be significantly mutated in IPF‐LC. Recurrent focal amplifications in three chromosomal loci (3q26.33, 7q31.2, and 12q14.3) and 9p21.3 deletion were identified, and genes associated with the JAK–STAT signalling pathway were significantly amplified in IPF‐LC ( P = 0.012). This study demonstrates that IPF‐LC is genetically characterized by the presence of somatic mutations reflecting a variety of environmental exposures on the background of specific germline mutations, and is associated with potentially targetable alterations such as BRAF mutations. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.